GOI funds Epygen Biotech to make affordable COVID-19 vaccine for less than Rs. 150 against old and new variants
Mumbai, April 11, 2022: Epygen Biotech, an Indian Biopharmaceutical company engaged in research and manufacturing therapeutic proteins, has received funding...